NHS

Digital

As more people begin turning to conversational AI with their healthcare concerns, use is exposing areas for improvement.

News

After nearly two years of wrangling, ITF's Duvyzat can be used by the NHS to treat people living with Duchenne muscular dystrophy.

Market Access

News

UCB's Rystiggo can be used by the NHS as a backup treatment for people with the rare autoimmune and neuromuscular disease gMG, says NICE.

Market Access

The Association of the British Pharmaceutical Industry (ABPI)'s flagship annual conference took place on Thursday, 23rd April.

News

The launch of a new national research collaboration focused on Parkinson’s disease has been announced.